|
Combo ‘polypill' cuts heart disease deaths, new study finds
[NYP] One pill may be better than three.A yuge letdown for Big Pharma and the VAX crowd. Bill and Melinda are not going to be pleased with this development either. A heart medication known as a "polypill" reduced the chance of a secondary adverse cardiovascular event in individuals who previously had a heart attack, according to the findings of a study announced on Friday, August 26, at the European Society of Cardiology Congress (ESC 2022) in Barcelona, Spain. The cardiovascular mortality rate was lowered by 33%, the study found. While too late for many, ten percent would have been wonderful. Published in The New England Journal of Medicine, the study found that the drug, bearing the commercial name Trinomia, contains three medications: aspirin (100 mg), the angiotensin-converting enzyme inhibitor ramipril (2.5, 5, or 10 mg) and atorvastatin (20 or 40 mg), according to a news release. The Spanish National Center for Cardiovascular Research (CNIC) and Ferrer developed the polypill. Unlike the CDC, the CNIC appears to be interested in prevention and cures. Currently, the polypill is not available in the United States. Dr. Valentin Fuster, M.D., director of Mount Sinai Heart and physician-in-chief of Mount Sinai Hospital as well as general director of CNIC, led the trial. There it is again! That pesky Jewish philanthropist Simpson is to blame for all of this progress. The study’s results demonstrate "for the first time that the polypill — which contains aspirin, ramipril and atorvastatin — achieves clinically relevant reductions in the recurrent cardiovascular events among people who have recovered from a previous heart attack," he said in the release. Posted by: Besoeker 2022-08-28 |
| http://www.rantburg.com/poparticle.php?ID=642495 |